(Q44437972)

3 December 2017

Cardiovascular risk factors of sirolimus compared with cyclosporine: early experience from two randomized trials in renal transplantation (English)

1 reference

3 December 2017

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0041-1345(03)00241-0

1 January 2024

author name string

J-P Squifflet

3

1 reference

3 December 2017

Sirolimus European Renal Transplant Study Group

5

1 reference

3 December 2017

C. Legendre

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742488

1 January 2024

J. M. Campistol

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742488

1 January 2024

J. T. Burke

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742488

1 January 2024

language of work or name

English

0 references

publication date

1 May 2003

1 reference

full work available at URL

3 December 2017

https://api.elsevier.com/content/article/PII:S0041134503002410?httpAccept=text/xml

1 reference

DOI

https://api.crossref.org/works/10.1016/S0041-1345(03)00241-0

https://api.elsevier.com/content/article/PII:S0041134503002410?httpAccept=text/plain

1 January 2024

1 reference

DOI

https://api.crossref.org/works/10.1016/S0041-1345(03)00241-0

Transplantation Proceedings

1 January 2024

published in

1 reference

3 December 2017

35

1 reference

3 December 2017

3 Suppl

1 reference

3 December 2017

151S-153S

1 reference

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900241-0

7 January 2021

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900241-0

7 January 2021

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900241-0

7 January 2021

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900241-0

7 January 2021

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900241-0

7 January 2021

Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study

1 reference

https://api.crossref.org/works/10.1016%2FS0041-1345%2803%2900241-0

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference